Fund Holdings — EcoR1 Capital, LLC

Total Portfolio Value:
$2.03B
Total Bought:
$294.06M
Total Sold:
$118.90M
Net Transaction:
+$175.16M
Notable People:
Scott Eric Perlen
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Zymeworks Inc.(ZYME)22,970,38822,970,3880$600.45M$608.49M29.91%+$8.04M
Anaptysbio Inc7,880,0947,880,0940$531.91M$396.05M19.47%-$135.85M
CG Oncology, Inc.(CGON)1,494,3001,871,892+377,592$106.17M$132.70M6.52%+$26.53M
Eton Pharmaceuticals, Inc.(ETON)2,171,9382,470,920+298,982$78.62M$127.23M6.25%+$48.60M
First Tracks Biotherapeutics3,174,5193,174,5190$63.87M$112.50M5.53%+$48.63M
Aktis Oncology, Inc.(AKTS)4,824,4694,824,4690$155.49M$93.93M4.62%-$61.56M
CRISPR Therapeutics AGNAMEN AKT(CRSP)1,389,2761,389,2760$75.77M$76.85M3.78%+$1.08M
Alto Neuroscience, Inc.SHSCOM(ANRO)02,232,000+2,232,000$0$56.98M2.80%+$56.98M
Lakefront Biotherapeutics NVADR(LKFT)1,667,1191,667,1190$49.98M$49.43M2.43%-$550.1K
Erasca, Inc.(ERAS)330,0002,950,000+2,620,000$6.05M$43.25M2.13%+$37.20M
ORIC Pharmaceuticals, Inc.(ORIC)6,728,1163,028,116-3,700,000$72.87M$40.79M2.01%-$32.08M
Neurogene Inc.(NGNE)1,271,3421,271,3420$39.98M$35.37M1.74%-$4.61M
Attovia Therapeutics IncCOM ADDED02,024,010+2,024,010$0$34.69M1.71%+$34.69M
Fulcrum Therapeutics, Inc.(FULC)6,549,8666,803,785+253,919$23.97M$25.17M1.24%+$1.20M
Adarx Pharmaceuticals IncCOM ADDED01,150,000+1,150,000$0$22.93M1.13%+$22.93M
Stoke Therapeutics, Inc.(STOK)735,000835,000+100,000$24.05M$21.71M1.07%-$2.34M
Zenas BioPharma, Inc.(ZBIO)789,500789,5000$20.04M$21.29M1.05%+$1.26M
Electra Therapeutics IncCOM ADDED01,700,000+1,700,000$0$19.13M0.94%+$19.13M
Atara Biotherapeutics Inc1,552,0001,552,0000$17.82M$13.19M0.65%-$4.62M
Capricor Therapeutics, Inc.(CAPR)01,376,580+1,376,580$0$13.04M0.64%+$13.04M
Xencor, Inc.(XNCR)0500,000+500,000$0$12.47M0.61%+$12.47M
Odyssey Therapeutics Inc555,555555,5550$10.39M$12.34M0.61%+$1.95M
Aura Biosciences, Inc.(AURA)1,666,6671,666,6670$11.83M$10.47M0.51%-$1.37M
Nurix Therapeutics, Inc.(NRIX)270,000375,000+105,000$6.55M$8.89M0.44%+$2.34M
Braveheart Bio IncSHSCOM ADDED0416,700+416,700$0$8.42M0.41%+$8.42M
Pharvaris N V
COM
235,000235,0000$8.13M$7.45M0.37%-$672.1K
Eikon Therapeutics, Inc.(EIKN)732,606855,634+123,028$9.56M$6.88M0.34%-$2.68M
Eloxx Pharmaceuticals Inc400,000400,0000$5.55M$6.12M0.30%+$572.0K
Aardvark Therapeutics Inc396,194720,028+323,834$2.28M$3.79M0.19%+$1.51M
BridgeBio Oncology Therapeutics, Inc.(BBOT)2,823,126889,607-1,933,519$21.51M$3.65M0.18%-$17.86M
Tcgx Acquisition CorpCL AORD ADDED0250,000+250,000$0$3.13M0.15%+$3.13M
Zura Bio LimitedCL A(ZURA)1,179,715679,715-500,000$6.96M$2.83M0.14%-$4.13M
Helix Acquisition Corp. IIICL A(HLXC)200,000200,0000$2.13M$2.12M0.10%-$4.0K
Contineum Therapeutics, Inc.CL A(CTNM)064,303+64,303$0$862.9K0.04%+$862.9K
Legend Biotech CorporationADS(LEGN)800,0000-800,000$23.10M$0—-$23.10M
MBX Biosciences, Inc.(MBX)388,5000-388,500$21.45M$0—-$21.45M
Mereo BioPharma Group plcADS(MREO)1,000,0000-1,000,000$317.7K$0—-$317.7K
Phathom Pharmaceuticals, Inc.(PHAT)625,0000-625,000$6.78M$0—-$6.78M
Relay Therapeutics, Inc.(RLAY)697,9480-697,948$13.06M$0—-$13.06M
Surrozen, Inc.W EXP 08 01 203(SRZN)4,4440-4,444$115.3K$0—-$115.3K
Page 1 of 1
EcoR1 Capital, LLC — 13F Holdings — Q3 2026 | TickerTrail